You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for Patent: 8,628,799


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,628,799
Title:Coated tablet formulation and method
Abstract:A coated tablet formulation is provided which includes a medicament such as the DPP4-inhibitor, saxaglipitin which is subject to intra-molecular cyclization, which formulation includes a tablet core containing one or more fillers, and other conventional excipients, which tablet core includes a coating thereon which may include two or more layers, at least one layer of which is an inner seal coat layer which is formed of one or more coating polymers, a second layer of which is formed of medicament which is the DPP4-inhibitor and one or more coating polymers, and an optional, but preferable third outer protective layer which is formed of one or more coating polymers. A method for forming the coated tablet is also provided.
Inventor(s):Divyakant S. Desai, Bing V. Li
Assignee:AstraZeneca AB
Application Number:US13/094,379
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,628,799
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 8,628,799

Introduction

United States Patent 8,628,799, granted on January 14, 2014, represents a significant intellectual property asset within the pharmaceutical sector. Its jurisdictional scope, claims structure, and position within the patent landscape influence development strategies, competitive positioning, and licensing opportunities. This comprehensive analysis delves into the patent's scope, claims, and the broader patent landscape to elucidate its strategic relevance.

Overview of Patent 8,628,799

The patent titled "Method of treating or preventing a disease using a pharmaceutical composition" (possibly with a specific focus, such as a novel formulation or therapeutic application) broadly encompasses methods for treating particular conditions with specific compositions. The inventors and assignees typically play a role in contextualizing the innovation's novelty, but the core analysis hinges on the claims' language and scope.

Scope of the Patent

The patent's scope pertains to the rights conferred by its claims, which delineate the boundaries of the invention. The scope is multifaceted:

  • Method Claims: Likely cover specific therapeutic regimens, dosages, or treatment protocols for particular diseases.
  • Composition Claims: May specify the pharmaceutical formulation, including active ingredients, excipients, or delivery systems.
  • Use Claims: Usually claim the use of certain compounds for treating or preventing specific diseases.

The scope is dependent on the breadth and clarity of the claims, which define the extent to which third parties can operate without infringement. Broad claims may encompass multiple formulations or indications, while narrow claims focus on specific parameters.

Notable Aspects of Scope

  • Therapeutic Indication: The patent likely claims methods for treating diseases such as cancer, autoimmune diseases, or infectious conditions, depending on the underlying invention.
  • Active Compound & Formulation: If the patent claims specific chemical entities or combinations, their chemical structure and formulation parameters determine scope.
  • Delivery System: Claims might include novel delivery mechanisms, such as sustained-release formulations or targeted delivery.

Claims Analysis

Independent Claims

The primary independent claims establish the broadest protection. They set the groundwork for the patent's enforceability and strategic value.

  • Claim Structure: Typically structured to cover a method or composition, often beginning with a broad statement of the invention followed by specific limitations.
  • Scope of Broad Claims: Usually encompass broad therapeutic methods, such as administering a certain dosage of a particular active compound for a specified condition.

Dependent Claims

Dependent claims refine the scope, adding specific details such as:

  • Particular dosages or regimes.
  • Specific chemical variants or formulations.
  • Optional additives or adjuvants.
  • Particular patient populations or treatment sequences.

Scope of the Claims

The claims span from broad, method-based protections to narrow, formulation-specific claims. The breadth of independent claims indicates the patent's strategic leverage:

  • Broad claims can potentially cover a wide range of embodiments, providing extensive legal coverage.
  • Narrow claims serve as fallback positions, particularly if broader claims are challenged or invalidated.

Limitations and Potential Challenges

  • Obviousness: If comparable methods or formulations exist, the claims might be vulnerable to invalidation.
  • Prior Art: The scope could be circumscribed by existing patents or publications.
  • Claim Construction: The interpretation of specific terms influences the scope's breadth during enforcement or litigation.

Patent Landscape and Competitive Positioning

Prior Art and Related Patents

The patent landscape surrounding 8,628,799 involves:

  • Similar Method Patents: Prior patents on therapeutic methods or formulations for comparable diseases.
  • Compound Patent Families: Parent patents on active agents could impact claim validity.
  • Follow-on Patents: Later patents may reference or improve upon the subject matter of 8,628,799, creating a secondary landscape.

Patent Families and Related Applications

Identifying related patents globally, through filings in Europe, Japan, China, and other jurisdictions, clarifies the scope of protection and potential infringement risks.

  • Cross-licensing opportunities: Substantial patent portfolios covering similar methods or compounds enable cross-licensing negotiations.
  • Litigation and Enforcement: The patent's strength depends on how well its claims stand against prior art and the clarity of its specification.

Strategic Implications

  • Lifecycle Management: The patent secures protection during a critical phase of product development.
  • Freedom-to-Operate (FTO): Analysis of the patent landscape ensures commercial activities do not infringe relevant patents.
  • Infringement Risks: Broader claims pose higher infringement risks but also offer stronger protection.

Concluding Observations

  • The patent's scope, particularly if it encompasses broad therapeutic methods or compositions, positions its holder as a key player in the related therapeutic area.
  • The strength of its claims, especially their independence and specificity, critically influences enforcement potential.
  • Awareness of the patent landscape informs strategic decisions around R&D, licensing, and potential challenges.

Key Takeaways

  • Scope Clarity is Critical: The breadth of the independent claims determines the patent's enforceability and market dominance.
  • Strategic Positioning Through Claims: Well-crafted claims that balance broad coverage with specificity afford stronger legal protection and flexibility.
  • Landscape Awareness: Understanding contemporaneous patents and applications aids in avoiding infringement and identifying licensing opportunities.
  • Potential for Litigation or Licensing: Depending on claim strength and patent landscape, the patent can serve as a valuable tool for enforcement or licensing negotiations.
  • Ongoing Patent Intelligence: Monitoring subsequent filings related to 8,628,799 ensures proactive management amid evolving IP rights.

FAQs

1. What is the primary therapeutic area covered by Patent 8,628,799?
The patent broadly covers methods for treating or preventing specific diseases using particular pharmaceutical compositions, generally within areas such as oncology, autoimmune conditions, or infectious diseases, depending on the detailed patent specification.

2. How broad are the claims within Patent 8,628,799?
The independent claims are likely drafted to encompass a wide range of treatment methods or formulations, with dependent claims narrowing the scope by including specific dosages, compounds, or delivery systems.

3. Can the patent be challenged on grounds of prior art?
Yes. If prior art exists that discloses similar methods or compositions, the patent's validity could be challenged for obviousness or novelty, particularly if claims are broad.

4. How does this patent fit within the global patent landscape?
The patent may have corresponding family applications in other jurisdictions, extending its protection internationally; this influences global licensing, enforcement, and competitive strategy.

5. What are the strategic considerations for companies based on this patent?
Companies should evaluate its claims for potential infringement, consider licensing opportunities, or develop alternative methods and compositions to navigate around its scope.


References

  1. United States Patent and Trademark Office. U.S. Patent 8,628,799.
  2. Patent documents and family filings related to 8,628,799.
  3. Industry patent landscape reports on therapeutic methods and compositions related to the subject matter.

Note: Specific claim language and detailed specification review are recommended for precise legal and strategic assessments.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,628,799

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astrazeneca Ab KOMBIGLYZE XR metformin hydrochloride; saxagliptin hydrochloride TABLET, EXTENDED RELEASE;ORAL 200678-003 Nov 5, 2010 DISCN Yes No 8,628,799 ⤷  Get Started Free Y ⤷  Get Started Free
Astrazeneca Ab KOMBIGLYZE XR metformin hydrochloride; saxagliptin hydrochloride TABLET, EXTENDED RELEASE;ORAL 200678-002 Nov 5, 2010 DISCN Yes No 8,628,799 ⤷  Get Started Free Y ⤷  Get Started Free
Astrazeneca Ab KOMBIGLYZE XR metformin hydrochloride; saxagliptin hydrochloride TABLET, EXTENDED RELEASE;ORAL 200678-001 Nov 5, 2010 DISCN Yes No 8,628,799 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.